NVIDIA recently announced a major expansion of its Clara healthcare platform with new software and tools to help healthcare researchers, technology solutions providers and hospitals tackle the COVID-19 pandemic faster.

The first of this expansion is the availability of NVIDIA Clara Parabricks computational genomics software via a free, 90-day license to COVID-19 researchers. The software is capable of analyzing the whole human genome DNA sequence in under 20 minutes.

NVIDIA also introduced GPU-accelerated RNA-sequencing pipelines that return results in less than 2 hours, giving researchers critical insights into patient susceptibility to disease, its progression and response to treatment.

In addition, NVIDIA released a set of AI models that can help researchers detect and study infected patients through chest CT scan data. Jointly developed by NVIDIA’s applied research team and clinicians and data scientists at the National Institutes of Health (NIH) through a cooperative research and development agreement, the models used data from locations with high rates of COVID-19 infections, including China, Italy, Japan and the United States.

Source: www.healthcareitnews.com